glp 1 masld Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease GLP-1 Drugs in MASLD Tied
Description
Activated charcoal: May help absorb excess gas
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
What are the potential side effects of GLP-1 agonists
Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk
Curr Protoc Bioinformatics Chapter 5 , Unit 5.6 (2006)
